Average Co-Inventor Count = 3.71
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pfizer Corporation (5 from 4,455 patents)
2. Merck + Co., Inc. (3 from 4,770 patents)
3. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
4. Other (1 from 832,680 patents)
11 patents:
1. 8552193 - Alternative forms of the phosphodiesterase-4 inhibitor N-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide
2. 8129413 - Crystalline forms of MC4R agonist and process for synthesis
3. 7312334 - Method of preparing inhibitors phosphodiesterase-4
4. 6998488 - Process and intermediates for the preparation of 4-aryl piperidines
5. 6909002 - Method of preparing inhibitors of phosphodiesterase-4
6. 6869943 - Sorbitol dehydrogenase inhibitors
7. 6727392 - Process for the preparation of non-steroidal glucocorticoid receptor modulators
8. 6660740 - Sorbitol dehydrogenase inhibitors
9. 6596867 - Tartrate salt of a substituted dipeptide as growth hormone secretagogue
10. 6570020 - Process for the preparation of non-steroidal glucocorticoid receptor modulators
11. 6248717 - Tartrate salt of a substituted dipeptide as growth hormone secretagogue